{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@id": "https://bio.tools/pdestrian",
  "@type": "sc:SoftwareApplication",
  "biotools:primaryContact": [
    "Dr. Albert J. Kooistra",
    "Dr. Chris de Graaf"
  ],
  "sc:additionalType": [
    "Web API",
    "Command-line tool",
    "Web application",
    "Database portal"
  ],
  "sc:author": [
    "Division of Medicinal Chemistry (Vrije Universiteit Amsterdam)",
    "Chris de Graaf",
    "Albert J. Kooistra",
    "Chimed Jansen",
    "Georgi K. Kanev"
  ],
  "sc:contributor": [
    "TI Pharma grant T4-302",
    "Rob Leurs",
    "European Commission seventh Framework Programme FP7-HEALTH-2013-INNOVATION-1, PDE4NPD (no. 602666)",
    "Iwan J.P. de Esch"
  ],
  "sc:description": "The database revolves around the protein structure of catalytic PDE domains and the way PDE inhibitors can interact with them. It contains a systematic analysis of all phosphodiesterase (PDE) catalytic domain crystal structures present in the Protein Data Bank (PDB) with a focus on PDE-ligand interactions.",
  "sc:funder": [
    "TI Pharma grant T4-302",
    "European Commission seventh Framework Programme FP7-HEALTH-2013-INNOVATION-1, PDE4NPD (no. 602666)"
  ],
  "sc:name": "PDEStrIAn",
  "sc:operatingSystem": [
    "Mac",
    "Linux",
    "Windows"
  ],
  "sc:provider": [
    "Vrije Universiteit Amsterdam",
    "vu.nl"
  ],
  "sc:url": "http://pdestrian.vu-compmedchem.nl"
}